Elke Hattingen

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 576 citations · Full text

Medicine, Oncology, Pharmacology +16

Human Motor Corpus Callosum: Topography, Somatotopy, and Link between Microstructure and Function

Mathias Wahl, Birgit Lauterbach-Soon, Elke Hattingen et al. · Journal of Neuroscience · 2007 · 432 citations · Full text

Medicine, Anatomy, Neuroscience +17

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

Congcong Zhang, Michael C. Burger, Lukas Jennewein et al. · JNCI Journal of the National Cancer Institute · 2015 · 388 citations · Full text

Life Sciences, Immunology, Oncology +17

Cerebral Gliomas: Diffusional Kurtosis Imaging Analysis of Microstructural Differences

Peter Raab, Elke Hattingen, Kea Franz et al. · Radiology · 2010 · 367 citations

Medicine, Neurology, Radiology +17

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma

Johannes Rieger, Oliver Bähr, Gabriele D. Maurer et al. · International Journal of Oncology · 2014 · 277 citations · Full text

Medicine, Nutrition, Oncology +15